Gallbladder Polypoid Lesion: What to Do When Polyp Size and Risk Profile Point to Surveillance

Not every gallbladder polypoid lesion requires surgery. For certain size and risk combinations, a structured surveillance pathway defines the appropriate next steps.

Clinical scenario

This protocol applies in two distinct situations: patients with no risk factors for malignancy and a gallbladder polypoid lesion of 6–9 mm, or patients with one or more risk factors for malignancy and a lesion of 5 mm or less. The combination of polyp diameter and malignancy risk profile determines which pathway applies.

Management approach (partial overview)

Management involves serial ultrasound surveillance of the gallbladder at defined intervals — the complete schedule, decision points, and criteria for when to escalate are detailed in the full structured protocol.

Clinical goal: The aim is to detect any growth of the polypoid lesion over time. The protocol specifies the exact endpoint at which surveillance may be safely discontinued in the absence of growth.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1007/s00330-021-08384-w

If the patient has either no risk factors for malignancy and a gallbladder polypoid lesion of 6–9 mm, or risk factors for malignancy and a gallbladder polypoid lesion 5 mm or less, follow-up ultrasound of the gallbladder is recommended at 6 months, 1 year and 2 years.

Follow-up ultrasound of the gallbladder is recommended at 6 months, 1 year and 2 years. Follow-up should be discontinued after 2 years in the absence of growth.

View source ↗